Clinical Trial Update: Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacokinetic differences between intradermal and subcutaneous delivery of insulin and glucagon in people with Type 1 diabetes mellit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GLUCAGON (GLUCAGON)
• Insulin (insulin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Type 1 Diabetes | Phase 2 | Status: UNKNOWN